Form 4: CytoDyn Inc. (CYDY), Kelly Scott A., transaction 03/31/2022

Summary

A Form 4 filed with the Securities and Exchange Commission for Kelly Scott A., as printed, a director of CytoDyn Inc. (CYDY) whose officer title reads "CMO". Table I lists common stock acquired on 03/31/2022 (15,592 shares), 04/15/2022 (21,367), 04/30/2022 (18,029), 05/15/2022 (16,968) and 05/31/2022 (18,029), with direct ownership reaching 2,025,048 shares; 782,408 shares are owned indirectly, by spouse. The explanation says these are fully vested share awards under the issuer's 2012 Equity Incentive Plan, approved by the Compensation Committee, valued at the reduction in the reporting person's cash salary. The form is signed /s/ Antonio Migliarese, Attorney-In-Fact, and dated 06/07/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Kelly Scott A. (Last) (First) (Middle) 1111 MAIN STREET, SUITE 660 (Street) VANCOUVER WA 98660 (City) (State) (Zip) | Kelly Scott A. | (Last) | (First) | (Middle) | 1111 MAIN STREET, SUITE 660 | VANCOUVER | WA | 98660 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol CytoDyn Inc. [ CYDY ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) CMO | X | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | CMO
3. Date of Earliest Transaction
 (Month/Day/Year) 03/31/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 03/31/2022 | A | 15,592 (1) | A | $ 0.00 | 1,950,655 | D
Common Stock | 04/15/2022 | A | 21,367 (1) | A | $ 0.00 | 1,972,022 | D
Common Stock | 04/30/2022 | A | 18,029 (1) | A | $ 0.00 | 1,990,051 | D
Common Stock | 05/15/2022 | A | 16,968 (1) | A | $ 0.00 | 2,007,019 | D
Common Stock | 05/31/2022 | A | 18,029 (1) | A | $ 0.00 | 2,025,048 | D
Common Stock | 782,408 | I | By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Explanation of Responses:
1. Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.
Remarks:
EX 24 - Power of Attorney
/s/ Antonio Migliarese, Attorney-In-Fact | 06/07/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_CYDY_4_filed2022-06-08_0001104659-22-069307.xml

Size

18,375 bytes

SHA-256

39f04d08c2779acd05653c976686d563353d5b2b9f61d7d0f7fc9b4b022b5a52

Our copy

SEC_CYDY_4_filed2022-06-08_0001104659-22-069307.xml

Original

www.sec.gov